New MRI technique could predict kidney cancer type and Post-Surgery outcomes
NCT ID NCT06116253
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses special MRI scans to look at kidney tumors in 39 people scheduled for surgery. The goal is to see if these scans can tell whether a tumor is cancerous and what type it is, as well as predict how well the kidney will work after part of it is removed. No new treatments are being tested—only imaging methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET scan could reveal kidney cancer drug success in weeks, not months
- Kidney tumor ablation: does it destroy cancer and boost well-being?
- Blood test aims to spot hidden cancer cells in 9 tumor types
- New imaging registry aims to sharpen cancer treatment precision
- Personalized cancer vaccine shows promise in early trial
- Robot surgery showdown: single port vs multi port for cancer